Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan | Patent Number 09452162

US 09452162 B2
Application Number14406776
Publication NumberUS 20150182521 A1
Pendency3 years, 3 months, 18 days
Filled DateJun 12, 2013
Priority DateJun 13, 2012
Publication DateJul 2, 2015
Expiration DateJun 12, 2032
Inventor/ApplicantsJonathan Basil Fitzgerald
Jaeyeon Kim
Navreet Dhindsa
Clet Niyikiza
Peter Laivins
Eliel Bayever
Victor Moyo
ExaminesSTRONG, TORI
Art Unit1629
Technology Center1600
Assignments
Ipsen Biopharm Ltd.
Current
Merrimack Pharmaceuticals
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.